Healthcare provider profile · identity verified

Joseph Mark Eisenberg, M.D.

Family Practice · GRESHAM, OR · NPI 1063749802

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	597	128
Lisinopril	Lisinopril	239	62
Amlodipine Besylate	Amlodipine Besylate	181	46
Losartan Potassium	Losartan Potassium	174	34
Omeprazole	Omeprazole	170	35
Gabapentin	Gabapentin	146	34
Trazodone Hcl	Trazodone Hcl	139	30
Metformin Hcl Er	Metformin Hcl	136	34
Famotidine	Famotidine	133	34
Tamsulosin Hcl	Tamsulosin Hcl	127	22
Metoprolol Succinate	Metoprolol Succinate	118	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	106	25
Levothyroxine Sodium	Levothyroxine Sodium	101	23
Albuterol Sulfate Hfa	Albuterol Sulfate	98	34
Metformin Hcl	Metformin Hcl	98	20
Sertraline Hcl	Sertraline Hcl	94	18
Hydrochlorothiazide	Hydrochlorothiazide	79	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	76	21
Allopurinol	Allopurinol	72	13
Furosemide	Furosemide	72	17
Carvedilol	Carvedilol	66	14
Glipizide Er	Glipizide	64	19
Quetiapine Fumarate	Quetiapine Fumarate	60	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	60	suppressed
Fluticasone Propionate	Fluticasone Propionate	52	19
Jardiance	Empagliflozin	52	15
Propranolol Hcl	Propranolol Hcl	52	suppressed
Duloxetine Hcl	Duloxetine Hcl	50	11
Eliquis	Apixaban	49	suppressed
Alendronate Sodium	Alendronate Sodium	46	suppressed
Finasteride	Finasteride	46	suppressed
Bupropion Xl	Bupropion Hcl	44	suppressed
Divalproex Sodium Er	Divalproex Sodium	44	suppressed
Topiramate	Topiramate	43	suppressed
Clonazepam	Clonazepam	42	suppressed
Baclofen	Baclofen	39	suppressed
Spironolactone	Spironolactone	39	12
Aripiprazole	Aripiprazole	37	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Potassium Chloride	Potassium Chloride	37	suppressed
Clotrimazole	Clotrimazole	36	12
Simvastatin	Simvastatin	36	suppressed
Farxiga	Dapagliflozin Propanediol	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Hydrocortisone	Hydrocortisone	32	19
Lovastatin	Lovastatin	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Dapagliflozin	Dapagliflozin Propanediol	29	suppressed
Lactulose	Lactulose	28	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Benztropine Mesylate	Benztropine Mesylate	27	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Ibuprofen	Ibuprofen	26	12
Metoprolol Tartrate	Metoprolol Tartrate	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	13
Oxycodone Hcl	Oxycodone Hcl	25	14
Latanoprost	Latanoprost	24	suppressed
Atrovent Hfa	Ipratropium Bromide	23	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Mupirocin	Mupirocin	23	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Loperamide	Loperamide Hcl	20	suppressed
Lurasidone Hcl	Lurasidone Hcl	20	suppressed
Torsemide	Torsemide	20	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	19	suppressed
Naproxen	Naproxen	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Ozempic	Semaglutide	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Prednisone	Prednisone	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Atenolol	Atenolol	15	suppressed
Haloperidol	Haloperidol	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Dapagliflozin-Metformin Er	Dapaglifloz Propaned/Metformin	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Clonidine Hcl Er	Clonidine Hcl	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Lithium Carbonate Er	Lithium Carbonate	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Risperidone	Risperidone	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Felodipine Er	Felodipine	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Perphenazine	Perphenazine	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	11	suppressed
Travoprost	Travoprost	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error